A Philadelphia jury has awarded nearly $28 million to the plaintiffs in the first bellwether trial to take place in state court over the blood thinner Xarelto. The verdict comes after three straight losses for plaintiffs in federal court.

The jury handed up the verdict against Bayer and Janssen Pharmaceuticals late morning Tuesday, awarding plaintiff Lynn Hartman $1.8 million in compensatory damages and $26 million in punitive damages. The verdict came after nearly one month of trial before Philadelphia Court of Common Pleas Judge Michael Erdos.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]